Fenfei Zou

Inhibition of ABCB1 Overcomes Cancer Stem Cell–like Properties and Acquired Resistance to MET Inhibitors in Non–Small Cell Lung Cancer

Teppei Sugano, Masahiro Seike, Rintaro Noro et al. · Molecular Cancer Therapeutics · 2015 · 76 citations

Medicine, Oncology, Pharmacology +16

Overcoming drug-tolerant cancer cell subpopulations showing AXL activation and epithelial-mesenchymal transition is critical in conquering ALK-positive lung cancer

Shinji Nakamichi, Masahiro Seike, Akihiko Miyanaga et al. · Oncotarget · 2018 · 42 citations · Full text

Medicine, Oncology, Pharmacology +17

MET FISH-positive status predicts short progression-free survival and overall survival after gefitinib treatment in lung adenocarcinoma with EGFR mutation

Rintaro Noro, Masahiro Seike, Fenfei Zou et al. · BMC Cancer · 2015 · 32 citations · Full text

Medicine, Molecular Biology, Oncology +17

Prognostic Significance of NSCLC and Response to EGFR-TKIs of EGFR-Mutated NSCLC Based on PD-L1 Expression

Kenichi Kobayashi, Masahiro Seike, Fenfei Zou et al. · Anticancer Research · 2018 · 22 citations · Full text

Medicine, Immunology, Oncology +17

AXL and GAS6 co-expression in lung adenocarcinoma as a prognostic classifier

Masahiro Seike, Cheol-Hong Kim, Fenfei Zou et al. · Oncology Reports · 2017 · 19 citations · Full text

Medicine, Molecular Biology, Oncology +16